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Abstract
Background: The heterogeneity observed regarding persistence, and subsequent fecal shedding pattern of the
Salmonella Senftenberg (S. Senftenberg) serovar in chicken’s calls for development of the optimized immunization
strategy which can provide protection against various S. Senftenberg isolated. Optimization of an immunization
strategy with a live attenuated S. Senftenberg (Δlon and ΔcpxR) vaccine candidate (JOL1587) was undertaken in
this study to evaluate the ability of a homologous prime-boost immunization strategy (using JOL1587) to confer
protection against four different S. Senftenberg isolates in chickens.
Results: After oral immunization with JOL1587, the humoral, mucosal and cell-mediated immune responses were
significantly higher in double immunized chickens than in single immunized and control group chickens. A significant
increase in the multifunctional cytokine IL-6 and in helper and cytotoxic T cell populations after a booster immunization
also indicated the advantage of double over single immunization. The four different S. Senftenberg field isolates were
characterized by their persistence levels in chickens, and were subsequently used for challenge experiments to evaluate
the differences in protective efficacy conferred by single and double immunization. Chickens from the doubleimmunized
group exhibited significant reduction in the shedding of all four wild-type S. Senftenberg challenge strains below the
detection limit in the fecal samples. Single immunized chickens showed a decrease in fecal shedding, but failed to exhibit
complete protection against all the challenge strains.
Conclusion: Although single immunization with JOL1587 showed a reduction in the fecal shedding of challenge strains,
only the homologous prime-boost immunization strategy provided an adequate immune response for increased
protection against all four challenge strains of S. Senftenberg from the feces of chickens.
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Background
The nontyphoidal serovars of the gram-negative patho-
gen Salmonella enterica are a leading cause of invasive
bacterial gastroenteritis in humans [1]. According to the
Centers for Disease Control and Prevention (CDC),
there are 94 million cases of nontyphoidal gastroenteritis
and 115,000 deaths reported annually in the worldwide
human population. The Salmonella enterica subsp.
Enterica serovar Senftenberg (S. Senftenberg) is one of
the nontyphoidal serotypes (NTS) that was isolated from
several outbreaks of gastroenteritis in humans [2–4]. S.
Senftenberg is a gram-negative, facultative, intracellular
pathogen affecting both poultry and humans [5, 6]). The
Salmonella pathogen is transmitted to humans either
through direct contact with an infected animal or by
consumption of contaminated food and water. The sero-
var S. Senftenberg is primarily associated with hatcher-
ies, but recent reports have suggested its emergence and
persistence in poultry environments throughout the
rearing season. This could pose a potential risk of
contamination of poultry products [7, 8]. Moreover, S.
Senftenberg cells are reported to tolerate desiccation
and survive routine cleaning and disinfection proce-
dures, enabling them to persist longer and transmit
more easily to other poultry and humans [8]. The
hallmark of S. Senftenberg infection in chickens is its
high colonization of the cecum, which in turn leads
to an asymptomatic carrier state in chickens [7]. Various
strains of S. Senftenberg isolated from different
poultry outbreaks were analyzed for their persistence
and fecal shedding patterns in the cecum [9]. As pre-
viously reported, a coordinated immune response
from the systemic and the mucosal arms of the immune
system is needed for clearance of Salmonella infection
[10]. Therefore, generation of both a systemic and a
mucosal immune response locally in the intestine is
essential for the control of S. Senftenberg colonization
and fecal shedding.
Homologous immunization with a S. Senftenberg
vaccine can be an approach for managing persistent in-
fection of S. Senftenberg in hatcheries as well as poultry
farms. Recently, we developed a live attenuated (Δlon
and ΔcpxR) S. Senftenberg vaccine candidate strain
(JOL1587) to provide protection against S. Senftenberg
[11]. The fact that different S. Senftenberg strains exhibit
variation in the fecal shedding pattern and extent of
colonization in the cecum underscores the need for
optimization of the immunization strategy with JOL1587.
The principle objective of this study was to generate
a robust systemic and mucosal immune response to
prevent fecal shedding of the persistent and the non-
persistent S. Senftenberg strains. We evaluated the
mucosal and systemic immune response generated in
chickens following single or double immunization with
a live attenuated mutant of S. Senftenberg (Δlon and
ΔcpxR). The ability to confer a protective immune
response by mucosal immunization was evaluated by
assessing the rate of fecal shedding and persistence of
four different wild-type strains of S. Senftenberg in
challenged chickens.
Methods
Preparation of the mutant and challenge strain
The attenuated mutant of S. Senftenberg JOL1587 was
constructed by deleting the lon and cpxR genes from
wild-type S. Senftenberg JOL1556 by the allelic exchange
method described previously [11, 12]. Four strains of S.
Senftenberg (JOL1557, JOL1815, JOL1816 and JOL1817)
isolated from different field outbreaks in chickens and
characterized for persistence in the caecum were used
for the challenge study. The wild-type strains were char-
acterized for presence of the specific pathogenicity island
(SPI) related genes by PCR (Table 1). All bacterial strains
were cryopreserved as frozen glycerol cultures in Luria-
Bertani (LB) broth at−80 °C. The glycerol stocks were
revived by streaking the thawed cultures on LB agar and
incubating at 37 °C for 24 h. A single colony was picked
from overnight grown culture, inoculated in LB broth at
1:20 dilution, and grown in shaker culture until the
optical density at 600 nm (OD600) reached 0.6. The
culture was adjusted to a suitable concentration before
inoculation into chickens.




Group Subgroup Days post inoculation
1 3 7 9 14 21 28
JOL1557 A A1 100a 100 100 100 100 100 100
B B1 100 60 40 40 40 40 40
C C1 100 60 40 40 0 0 0
JOL1815 A A2 100 100 100 100 100 80 80
B B2 100 40 60 40 60 60 40
C C2 100 60 40 10 0 0 0
JOL1816 A A3 100 100 100 100 100 100 100
B B3 100 40 0 40 40 60 60
C C3 100 60 40 40 0 10 0
JOL1817 A A4 100 100 100 100 100 80 80
B B4 100 40 60 40 60 40 0
C C4 100 60 40 10 0 0 0
A: PBS inoculated group; B: Prime immunized group and C: Prime-boost
immunized group
Each major group A, B and C are further sub-divided into four subgroups and
challenged with JOL1557, JOl1815, JOL1816 and JOL1817, respectively
aPercentage population tested positive for recovery of the S. Senftenberg in
fecal samples
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Chicken immunization and challenge experiments
For chicken experimentation, female day-old layer chick-
ens (Brown Nick, n = 75) were procured from JOINBIO
hatchery located in the yongin-si, South Korea. The
chickens were divided into three groups (n = 25). The
strategy for the immunization and challenge study is ex-
plained in Table 2. All animals were provided with ad
libitum antibiotic-free feed and water. At the fourth
week of age, group A was inoculated orally with PBS to
serve as a non-immunized control and groups B and C
were inoculated orally with a JOL1587 suspension con-
taining 1 × 108 colony forming units (CFUs). Further,
group C was given a booster dose orally at the 8 week
of age with a JOL1587 suspension containing 1 ×
108 CFUs. Post-immunization and booster, the serum
and intestinal lavage samples were collected from six
randomly selected chickens from the pool of 25 chick-
ens in each group.
Collection of the intestinal wash for sIgA
The intestinal lavage samples were collected for meas-
urement of the secretory IgA levels according to a proto-
col described elsewhere [13]. Briefly, chickens were
taken off feed for 16 h. The off-feed chickens were orally
administered 5 mL of lavage solution (0.2 M Na2SO4,
0.2 M NaHCO3, 0.1 M KCl, 0.25 M NaCl, and 16.25%
polyethylene glycol in distilled water) and kept in clean,
disinfected buckets. Thirty minutes post-administration,
the chickens were injected intramuscularly with 200 μl
of a 5% pilocarpine solution. The chickens were ob-
served for mucinous droppings over a period of thirty
minutes. The mucinous droppings were collected in
microcentrifuge tubes containing 1× soybean trypsin
protease inhibitor and 50 mM EDTA solution. Samples
were preserved by adding 10 μL each of 5% bovine
serum albumin, 10% sodium azide and 1% PMSF (phe-
nylmethylsulfonyl fluoride). Samples were stored at
−20 °C until analysis.
Enzyme-linked immunosorbent assay (ELISA)
The development of S. Senftenberg-specific humoral and
mucosal immunity in response to JOL1587 immunization
in chickens was evaluated by estimating the variation in
plasma IgG and intestinal sIgA levels by S. Senftenberg
antigen-specific indirect ELISA. The outer membrane
protein fraction (OMP) was extracted from wild-type S.
Senftenberg as described elsewhere (Osborn and Munson,
1974). The levels of OMP specific IgG antibodies in the
plasma of the immunized chickens were determined using
an indirect ELISA. Briefly, 96-well Microlon® ELISA plates
(Greiner Bio-One GmbH, Fricken hausen, Germany) were
coated with OMP (50 μg/mL) and blocked with 5% skim
milk powder in PBS. For total IgG and sIgA detection, the
ELISA plates were incubated with an intestinal wash (1:5
dilution) and plasma (1:100 dilution) and then incubated
with horseradish peroxidase (HRP)-conjugated goat anti-
chicken IgG and IgA at a 1:100,000 dilution for 1 h. The
plates were developed with o-phenylenediamine dihy-
drochloride substrate (Sigma-Aldrich, St. Louis, MO,
USA) and read at 492 nm.
Lymphocyte proliferation assay (LPA)
The LPA stimulation indices were calculated 3 weeks post-
prime- and –booster immunization to estimate the cellular
immune response generated after JOL1587 immunization
in chickens. From each group (A, B and C) heparinized
blood samples were collected from six randomly selected
chickens from the pool of 25 chickens. Cells were stimu-
lated with soluble antigen prepared from the S. Senftenberg
wild-type strain, as described elsewhere [14]. Soluble anti-
gen was prepared from the wild-type S. Senftenberg strain
JOL1556. Briefly, the overnight grown bacterial cell culture
were pelleted and resuspended in PBS. The bacterial
suspension was sonicated for 5 min, and pelleted by centri-
fugation at 5000 × g for 60 min at 4 °C. The supernatant
containing the sonicated bacterial cell protein suspen-
sion (sbcp) was collected and used as the soluble
antigen. Post-inoculation, the peripheral blood mono-
nuclear cells (PBMCs) were separated from the hepa-
rinized blood collected from the jugular veins of five
randomly selected chickens per group. Blood was carefully
loaded on Histopaque-1083 (Sigma-Aldrich, St. Louis,
MO, USA) and centrifuged at 400 × g for 40 min at room
temperature. The buffy coat at the interface was sus-
pended in RPMI-1640 medium (HyClone Laboratories,
South Logan, UT, USA). The PBMCs were adjusted to a
1 × 106 cells/mL final concentration in the RPMI-1640
medium and distributed in triplicate to 96-well tissue cul-
ture plates. The plates were incubated with medium alone
Table 2 Immunization and challenge strategy
Group N Immunization Subgroups Animal No. Challenge
strainPrimary Booster












Kamble and Lee BMC Veterinary Research  (2017) 13:39 Page 3 of 11
or medium containing 4 μg/mL of the soluble antigen of
S. Senftenberg at 40 °C with 5% CO2 for 72 h. Cell prolif-
eration was measured by using thiazolyl blue tetrazolium
bromide (MTT) dye (Sigma-Aldrich, St. Louis, MO, USA)
as per the manufacturer’s protocol. The blastogenic
response was expressed as mean stimulation index (SI),
which was calculated as the ratio of the average OD of the
stimulated/unstimulated wells.
Flow cytometry
Post-booster immunization, variations in the JOL1587-
specific helper (CD3 + CD4+) and cytotoxic (CD3 + CD8
+) T cell populations were analyzed following ex vivo
stimulation of peripheral blood mononuclear cells
(PBMCs) with soluble antigen extracted from wild-type
S. Senftenberg. PBMCs were separated from blood sam-
ples of five chickens from each group (A, B and C) at 1
week post-prime and booster immunization. The isolated
PBMCs were stimulated ex vivo with soluble antigen ex-
tracted from wild-type S. Senftenberg. The stimulated
PBMCs were stained with anti-CD3, anti-CD4 and anti-
CD8 antibodies, as described elsewhere [15]. Briefly, a
total of 1 × 106 PBMCs were stained with appropriately
diluted mouse anti-chicken CD3-FITC, CD4-APC and
CD8-RPE (Southern Biotech, USA). After incubation,
all stained samples were washed three times with PBS
and analyzed with a flow cytometer (Miltenyi Biotech,
Germany). A total of 10,000 events were recorded and
analyzed using the FlowJo single cell analysis software.
Relative quantification of cytokines by real-time
quantitative reverse transcriptase PCR (qRT-PCR)
The cytokine response was evaluated after prime and
booster immunization in PBMCs following ex vivo
stimulation with the soluble antigen of S. Senftenberg.
The qRT-PCR method was employed for relative quanti-
fication of IL-6, IFN-γ, and IL-2 cytokine mRNA levels.
The RNA was isolated from PBMCs separated at ten
days post prime and booster vaccination. The house-
keeping gene β-actin was used as an endogenous
control for normalization of the sample Ct values. The
comparative 2-ΔΔCt method was used for the relative
quantification of the fold change in the cytokine mRNA
levels [16].
Fecal shedding of the different strains of S. Senftenberg
At the twelve week of age, chickens from each group
were further separated into four sub-groups containing
six chickens each, and orally challenged individually with
virulent wild-type (WT) S. Senftenberg strain, JOL1557,
JOL1815, JOL1816, and JOL1817 (5 × 108 CFUs), re-
spectively. For fecal shedding, the fecal samples were
collected from six chickens in each sub-group using
sterile, buffered peptone water (BPW, Becton Dickinson,
USA). A ten-fold dilution of BPW was plated onto bril-
liant green agar (BGA, Becton Dickinson) and incubated
at 37 °C for 24 h. Samples showing colonies on BGA
were counted as positive. Negative samples were further
incubated in Rappaport-Vassiliadis R10 enrichment
broth (RV, Becton Dickinson) for 48 h at 42 °C. The
enriched culture was picked with a sterile loop and then
plated onto BGA. Samples that were positive after direct
plating or after enrichment were taken as positive for
harboring S. Senftenberg. The challenge strain was con-
firmed by PCR using S. Senftenberg serotype-specific
primers. The challenge strain was distinguished from
inoculated JOL1587 (Δlon/ΔcpxR) by using primer sets
specific to lon and cpxR genes. The enumeration of the
cfu per gram of tissue was performed as described
elsewhere [17].
Statistical analysis
The results of this study are expressed as means ± SEM
unless otherwise specified. A one-way ANOVA with
Bonferroni corrections was employed to analyze statis-
tical significance for expression levels of CD3 + CD4+ T
cells, CD3 + CD8+ T cells, cytokines, plasma IgG and in-
testinal sIgA. The values for the individual groups were
considered statistically significant if the P-values were
≤0.05 or ≤ 0.01. The fecal shedding data was converted
into percentage value for comparison. All analysis was
performed using the SPSS 16.0 (SPSS Inc., USA).
Results
Characterization of wild type S. Senftenberg strain
Four wild-type S. Senftenberg strains, JOL1557 (WT),
JOL1815 (WT), JOL1816 (WT) and JOL1817 (WT) were
characterized by PCR for presence of various SPI
specific genes (Table 3). The PCR data indicated the
size-specific amplification and presence of the SPI1, 2, 3,
4 and 5 specific analyzed genes in all four wild-type S.
Senftenberg strain (Data not shown). The four groups of
the non-immunized chickens were inoculated separately
with JOL1557 (WT), JOL1815 (WT), JOL1816 (WT)
and JOL1817 (WT) for evaluation of the persistence in
the cecum. The bacterial recovery experiment showed
that all the four wild-type strains were recovered from
cecum swabs on BGA plates until week four post-
inoculation.
Estimation of S. Senftenberg-specific humoral and
mucosal immune responses
Indirect ELISA estimated differences in humoral and
mucosal immune responses generated after single and
double immunization. Immunization of the chickens
with JOL1587 led to a significant rise (P ≤ 0.05) in the
IgG and sIgA levels in both the single and double immu-
nized groups relative to the control group chickens
Kamble and Lee BMC Veterinary Research  (2017) 13:39 Page 4 of 11
(Fig. 1). The effect of booster immunization was appar-
ent for both the plasma IgG and intestinal sIgA
responses in that levels of each increased significantly
(P ≤ 0.05) only in the double immunized group. The
chickens from the single immunized group (coinciding
with the timing for booster immunization) started exhi-
biting sharp and significant declines (P ≤ 0.05) in both
IgG and sIgA levels compared to the double immunized
group. The levels of IgG and sIgA in the single immu-
nized group became insignificant and similar to control
group chickens by eleven weeks of age (P ≤ 0.05, Fig. 1).
The non-immunized control group chickens showed in-
significant rise in S. Senftenberg-specific IgG and sIgA
levels throughout the observation period (Fig. 1).
Evaluation of S. Senftenberg-specific cellular immune
responses
As shown by the LPA results, the immunization of chick-
ens with JOL1587 successfully induced an S. Senftenberg-
specific cellular immune response in both single and
double immunized groups (Fig. 2). For calculation of
significant differences in the cellular immune response,
the SI value for an immunized group was compared with
control group chickens. The LPA results showed that the
cellular immune response in the double immunized group
was significantly elevated (P ≤ 0.05) after prime (1.6-fold)
as well as booster 2.0-fold) immunization (Fig. 2). The sin-
gle immunized chickens, which showed a significant rise
(1.7-fold, P ≤ 0.05) in SI value after prime immunization,
contrastingly showed an insignificant decline in the SI
value (1.5-fold, P ≤ 0.05) at eleven week of age.
Analyses of helper and cytotoxic T cell populations
For estimation of the differences in the helper and cyto-
toxic T cell populations, the CD3 + CD4+ and CD3 + CD8
+ T cell populations for the immunized groups were com-
pared with control group chickens. Both the single and
double immunized chickens showed a significant increase
(P ≤ 0.05) in cytotoxic T cell populations after prime-
Fig. 1 Graphical representation of the OD values for evaluation of
the plasma IgG and intestinal lavage sIgA responses to JOL1587
immunization in chickens. I) Plasma IgG levels, II) Intestinal lavage
sIgA levels. a: PBS-inoculated group; b: single immunized group and
c: double immunized group. The arrow denotes the time of booster
immunization in group C chickens. Values shown for each group are
the mean ± SEM of antibody levels (n = 6). The * symbol indicates a
significant increase in the antibody levels in the JOL1587 immunized
chickens compared to the control group chickens (P ≤ 0.05)
Table 3 List of primers used for detection of genes specificto different SPI
SPI Primers Sequence 5'–3' Amplicon Size (bp)
SPI1 invAE F CAGCGATATCCAAATGTTGC 2168
invAE R AAATGGCAGAACAGCGTCGTA
hilA F CTGCCGCAGTGTTAAGGATA 497
hilA R CTGTCGCCTTAATCGCATGT
avr F AGACTTATATTCAGCTATCC 1115
avr R ACATAACCCTGCTGTACCTG
SPI2 aa permease F ACCATTCAAGAGACAATTGG 1737
aa permease R GTCCTGTTCTGGTATTACGC
SPI3 mgtC F ATGAATCCCCAAAATTAAGG 1153
mgtC R AATCATCTGGCAAGTTAACG
SPI4 ABC Trans F CAGTCTATCACAGCAAGGCA 1409
ABC Trans R TTATCCGGAGAACAATCACG
SPI5 pipB F AATATTGGATGGGGGAAAAG 230
pipB R AACCTGACTCACGCAGACCT
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immunization. However, this failed to generate a signifi-
cant increase in the peripherally circulating helper T cell
populations as compared to the control group chickens
(Fig. 3I). Our experimental data showed that the signifi-
cant increase (P ≤ 0.05) in both the helper and cytotoxic T
cell populations was observed in the double immunized
group only after the booster immunization (Fig. 3I). The
quantitative estimation of the CD3+ CD4+ and CD3+
CD8+ T cell populations in the double immunized chick-
ens showed these were approximately 2.5- and 1.5- fold
higher than in the control group chickens, respectively
(P ≤ 0.05, Fig. 3II). After booster immunization, the
levels of the CD3 + CD4+ and CD3+ CD8+ T cell popu-
lations for the single immunized and control group
chickens were similar, with no fold change differences
observed (Fig. 3).
Cytokine mRNA expression levels
The fold changes observed in the mRNA copy number
of the IL-6, IFN-γ and IL-2 cytokines in the PBMCs
from control and immunized group chickens are shown
in Fig. 4. Both the single and double immunized groups
showed significant upregulation (P ≤ 0.05, Fig. 4) of the
IL-6, IFN-γ and IL-2 cytokines relative to control group
chickens. After quantitative estimation, IFN-γ and IL-2
cytokine mRNA expression levels were upregulated 10-
and 16-fold in the single and double immunized groups,
respectively (P ≤ 0.05, Fig. 4). IL-6 showed a 16- and 24-
fold increase in the single immunized group and a 16-
and 46-fold increase in the double immunized group
(P ≤ 0.05, Fig. 4).
Protective efficacy against different wild-type strains of S.
Senftenberg
The fecal colonization of the JOL1557, JOL1815, JOL1816,
and JOL1817 from the challenged chickens was evaluated
to determine the protective efficacy offered by JOL1587
immunization. The fecal samples obtained from the im-
munized and control group chickens showed direct and
post-enrichment recovery of all the challenge strains on
BGA plates. The colonization and persistence of different
S. Senftenberg was studied by challenging immunized as
well as control group chickens. We divided each major
group A, B and C post immunogenicity study into 4 sub-
groups with six birds each. Each sub-group was challenged
with different wild type S. Senftenberg (Table 2). Post-
challenge bacterial recovery from fecal samples was
performed to assess the protective efficacy. The bacterial
recovery data was expressed as mean CFU/gm of each S.
Senftenberg strain recovered from each sub-group (Fig. 5).
Individual variation in the CFU recovery data was
observed, hence mean value was calculated for each sub-
group. The control group chickens showed significantly
higher recovery of S. Senftenberg JOL1557, JOL1815,
JOL1816 and JOL1817 strain until day 9, 28, 28 and 21
than prime-boost group, respectively (GI. 5, p < 0.05).
Within immunized group, only the prime-boost immu-
nized group showed significantly lower and below detec-
tion limit recovery for JOL1557, JOL1815, JOL1816 and
JOL1817 from day 14 post-challenge (Fig. 5; p < 0.05).
Some chickens showed bacterial recovery only after en-
richment culture; therefore, we interpreted the enrichments
and direct recovery data as positive after for infected and
shedding chickens and negative for non-shedding chickens.
The percent population of positive (infected and shedding)
and negative (non-shedding) chickens for S. Senftenberg
infection are shown in Table 1. Total 80 to 100% chickens
from the non-immunized control group showed fecal re-
covery of the JOL1557, JOL1815, JOL1816, and JOL1817
challenge strains consistently up to 4 weeks post-challenge,
whereas the immunized chickens showed a significant
decrease in the percentage population of the chickens posi-
tive for fecal shedding of the challenge strains (Table 2).
Among the JOL1587 immunized chickens, the double im-
munized group showed significantly higher protection
against S. Senftenberg than the single immunized and
control group chickens (Table 2). Chickens from the double
immunized group showed reduction in the challenge strain
shedding below the detection level in the feces from day 9
post-challenge onward (Table 2). Although the single
immunized group showed a significant reduction in the
Fig. 2 Stimulation indices for measurement of a lymphocyte
proliferation response in the JOL1587-immunized and control group
chickens. a PBS-inoculated group; b Single immunized group and
c: Double immunized group. The LPA assay was performed at 7 and
11 weeks of age after the prime and booster immunizations, respectively.
The * symbol indicates a significant increase in the lymphocyte
proliferation response in the JOL1587 immunized chickens compared
to the control group chickens (P≤ 0.05). Total six samples were
analyzed which were collected from six randomly selected chickens
from group a, b and c
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Fig. 3 (See legend on next page.)
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number of chickens positive for fecal shedding of the chal-
lenge strains, this group failed to show complete reduction
in the shedding of wild–type S. Senftenberg below the de-
tection limit from all the chickens (Table 2).
Discussion
Contrary to other Salmonella serovars, the pattern of S.
Senftenberg infection in chickens is characterized by
colonization of the intestinal epithelium with very little
induction of the systemic immune response [18]. Infor-
mation regarding the quality and magnitude of the im-
mune response needed for optimal protection against S.
Senftenberg infection is sparse, and many factors still need
to be investigated. Previously we developed a S. Senftenberg
mutant strainJOL1587 (Δlon and ΔcpxR) for immunization
of the chickens against wild-type S. Senftenberg infection
[11]. In this study, we evaluated the magnitude and quality
of immune response generated by JOL1587 immunization
in chickens. Further, the generated immune response was
evaluated for its ability to protect chickens against four dif-
ferent wild-type isolates of S. Senftenberg.
Generation of Salmonella-specific IgG and sIgA antibodies
is essential for the development of acquired immune protec-
tion against NTS [19]. Because S. Senftenberg colonizes and
persists in the cecum of chickens, the induction of a sIgA
antibody response might be beneficial for the mucosal
clearance of S. Senftenberg. Salmonella-specific sIgAs in the
intestinal mucosa constitute a first line of defense by prevent-
ing bacterial penetration of the intestinal barrier through the
mechanism of immune exclusion [20, 21]. In this study, we
evaluated the potential of single and double immunization to
induce a plasma IgG and intestinal sIgA response in chick-
ens. From the ELISA results, it was evident that double
immunization induced significantly higher IgG and sIgA
levels than single immunization. It is possible that the
booster immunization activates memory B cells, producing
an increase in antibody titer by their rapid proliferation and
differentiation into plasma cells [22]. The observed decline in
the magnitude of IgG and sIgA levels in the single immu-
nized group contrary to the double-immunized group may
have been due to poor systemic invasion and lower levels of
colonization in the spleen. This has been observed previously
after experimental parenteral inoculation with S. Senftenberg
in chickens [7]. The ELISA results highlight the necessity of
a booster immunization in this case with JOL1857 to induce
better humoral and mucosal immune responses against S.
Senftenberg infection in chickens.
Along with humoral immunity, the generation of a
Salmonella-specific cellular immune response (CMI) is a
prerequisite for the establishment of immune protection
against Salmonella spp. in chickens [23]. The production
of CD4 and CD8 T cells as part of an adaptive cellular im-
mune response is crucial for the clearance of Salmonella
infection in mice [24]. Activated Salmonella-specific CD4
and CD8 T cells migrate to infected non-lymphoid tissues
and exert their effector functions to enable Salmonella
clearance [25]. In the present study, the single and double
immunized chickens showed a significant increase in their
LPA and CD8 T cell responses relative to control group
chickens, but failed to induce a CD4 T cell response after
primary immunization with JOL1857. Following oral
inoculation of attenuated Salmonella, the antigen-specific
CD4 T cell response is initially generated in the gut-
associated lymphoid tissue (GALT), a primary site for pro-
cessing intestinal immunogens in mice [26]. Because S.
Senftenberg serovars have been shown to colonize intes-
tinal epithelial cells following oral inoculation in chickens
[18], the Salmonella-specific CD4 and CD8 T cell re-
sponses observed in this study after primary immunization
with JOL1857 may be induced in the GALT of the chick-
ens. The fact that intestinal lymphoid tissue possesses very
few naïve CD3 +CD4+ T cells could explain the low T
helper cell response after primary immunization with
JOL1587 [27]. Only after the booster immunization was
a significant increase in the CD4 T-cell level observed
in the double immunized chickens. This significant in-
crease in the CD4 T cell levels observed following
booster immunization correlates with the increased anti-
body titers in the double immunized chickens. Salmon-
ella-specific antibodies have been shown to upregulate the
cellular immune response by amplifying the processing
and presentation of antigens from Salmonella to T helper
cells in mice [28, 29]. Overall, the prime-boost chickens
immunized with JOL1857 displayed a significant increase
in the S. Senftenberg-specific CMI response compared to
the single immunized chickens.
To further elucidate the role of the CMI response in S.
Senftenberg clearance from chickens, we investigated
(See figure on previous page.)
Fig. 3 FACS analysis for peripheral CD3 + CD4+ and CD3 + CD8+ T cell populations in the JOL1587-immunized and control group chickens. The
isolated PBMCs were stained with appropriately diluted fluorescein-isothiocyanate (FITC)-labeled anti-CD3, allophycocyanin (APC)-labeled anti-CD4,
and phycoerythrin (PE)-labeled anti-CD8 monoclonal antibodies. a: PBS-inoculated group; b: single immunized group and c: double immunized group.
(I) Representative dot plots for CD3 + CD4+ and CD3 + CD8+ T cell populations. The population is represented as a percentage of gated cells; (II) The
percentage of peripheral CD3 + CD4+ T cells; (III) The percentage of peripheral CD3 + CD8+ T cells. The values are shown as the mean ± SEM of five
chickens per group. The * symbol indicates a significant increase in the percentage of peripheral T lymphocytes in the JOL1587-immunized chickens
compared to the control group chickens (P≤ 0.05)
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differences in the expression patterns of the cytokines
IL-2, IFN-γ and IL-6 for immunized and control groups.
The chickens immunized with JOL1587 showed signifi-
cant upregulation of IFN-γ, IL-2 and IL-6 after receiving
the primary and booster immunizations. As studied in
mice infection model, the mechanisms employed by
IFN-γ, IL-2 and IL-6 for establishing protection against
Salmonella infection are diverse in nature [30–32]. The
cytokines IL-2 and IFN-γ are known to mediate immune
protection against Salmonella by up-regulating the
generation of Salmonella-specific cell-mediated and mu-
cosal immunity, respectively [33, 34]. The production of
IFN-γ in the intestinal mucosa is essential for the gener-
ation of mucosal immunity against Salmonella infection
[34]. In the absence of IFN-γ in the mucosa, infection
with Salmonella Typhimurium has been shown to pro-
duce increased invasion and disseminated infection with
septicemia in mice [34]. The multifunctional cytokine
IL-6 has also been shown to confer a protective effect at
the mucosal level against invasive Salmonella infection
[32, 35]. Upregulation in IL-6 levels can trigger the rapid
development of a cytotoxic T cell response against
Salmonella infection in mice [36, 37]. Our results
showed a correlation between an increase in IL-6 and
the production of S. Senftenberg-specific CD8 T cells
after booster immunization in the double immunized
group. Collectively, the results from the immunogenicity
study for JOL1587 in chickens suggest that the prime-
boost immunization protocol can induce significant
humoral, mucosal, and cellular immune responses against
the S. Senftenberg serovar in chickens.
Current evidence suggests that optimal protection
against Salmonella infection is conferred by vaccines that
produce a pattern of immune response homologous to
that induced by natural infection [38]. Hence, the ability of
the immune response generated in response to JOL1587
immunization to establish immune protection was evalu-
ated by challenging the chickens orally with four different
wild-type strains of S. Senftenberg. Systemic infection with
wild-type S. Senftenberg in chickens was reported to be
self-limiting in nature [9]. Heterogeneity regarding caecal
persistence and fecal shedding for various S. Senftenberg
strains in chickens represents a potential challenge for this
serovar’s suitability as a vaccine candidate [7]. The wild-
type S. Senftenberg strains used in this study were tested
positive for presence of SPI1, 2, 3, 4, and 5 specific gene
with persistence in cecum of chicken. Evaluation of fecal
shedding for the different challenge strains of wild-type S.
Senftenberg can provide a useful means of estimating the
protective efficacy conferred by JOL1587. The fecal shed-
ding data from the protective efficacy experiments showed
that, compared to the single immunization protocol, the
prime-boost immunization with JOL1587 was sufficient
for reduction of the wild-type S. Senftenberg recovery
below the detection level in the feces of the chickens.
Overall, the immunity generated in chickens by prime-
boost immunization with JOL1587 was sufficient to pro-
tect chickens against infection with various wild-type S.
Senftenberg strains.
Fig. 4 The IFN-γ, IL-2 and IL-6 cytokine profiles of in vitro-stimulated
PBMCs from the JOL1587-immunized and control group chickens.
The relative mRNA copy numbers were determined by qRT-PCR
using the comparative Ct method. I) Prime inoculation with JOL1587
at the fourth week of age and II) Prime-boost inoculation with
JOL1587 at the 8 week of age. a PBS-inoculated group; b Prime
immunized group and c Prime-boost immunized group. The *
symbol indicates a significant increase in the cytokine levels for the
JOL1587-immunized group compared to the control group chickens
(P ≤ 0.05).Total six splenocytes samples were analyzed which were
collected from six randomly selected chickens from group a, b and c
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Conclusion
Our results indicate that chickens double immunized
with JOL1587 can generate significant S. Senftenberg-
specific mucosal, humoral and cell-mediated immune
responses in chickens. Fecal shedding of the various S.
Senftenberg wild-type isolates was significantly reduced
below detection limit only in the double immunized
chickens. In conclusion, the prime-boost immunization
strategy of chickens with JOL1587 can provide a valu-
able method to prevent S. Senftenberg infection and
fecal shedding in chickens.
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